Protagonist Therapeutics Inc
PTGX
NASDAQ
Biotechnology
$155.10
USD
+3.68 (+2.43%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $9.93B
Volume 426.3K
Price Target
$151.00 – $186.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $186.00 and a min estimate of $151.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$168.50
+$53.8 vs prior
Implied Upside
+8.6%
+34.7% vs prior
Analyst Covering
2
-8 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
17%
Many ratings are older - consensus may be less current
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Richard Law | Goldman Sachs | Buy | Upgraded | 6 days ago | Plus | Plus | Plus |
Etzer Darout | BMO Capital | Buy | Maintained | 4 weeks ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
SMMT
Summit Therapeutics Inc
$13.35
▼ -4.6%
IONS
Ionis Pharmaceuticals Inc
$57.24
▲ +2.5%
KRYS
Krystal Biotech Inc
$332.27
▲ +1.2%
APGE
Apogee Therapeutics Inc
$134.55
▲ +0.1%
PRAX
Praxis Precision Medicines Inc
$366.81
▼ -0.5%
CYTK
Cytokinetics Inc
$74.13
▲ +0.9%
KYMR
Kymera Therapeutics Inc
$117.39
▲ +2.6%
HALO
Halozyme Therapeutics Inc
$98.66
▼ -2.0%
PCVX
Vaxcyte Inc
$58.07
▼ -1.3%
SYRE
Spyre Therapeutics Inc
$103.63
▲ +1.8%